Tudor Investment Corp
DNLI icon

Tudor Investment Corp’s Denali Therapeutics DNLI Stock Holding History

Tudor Investment Corp’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
+40,965
New +$842K ﹤0.01% 2384
2026
Q1 		– Sell
-53,683
Closed -$886K – 3756
2025
Q4 		$886K Sell
53,683
-2,685
-5% -$45.3K ﹤0.01% 2355
2025
Q3 		$818K Buy
56,368
+920
+2% +$13.2K ﹤0.01% 2398
2025
Q2 		$776K Sell
55,448
-17,149
-24% -$241K ﹤0.01% 2300
2025
Q1 		$987K Buy
+72,597
New +$1.39M ﹤0.01% 1824
2024
Q3 		– Sell
-58,523
Closed -$1.36M – 2790
2024
Q2 		$1.36M Sell
58,523
-13,128
-18% -$252K 0.01% 1296
2024
Q1 		$1.47M Buy
+71,651
New +$1.35M 0.01% 1170
2023
Q4 		– Sell
-42,020
Closed -$867K – 2467
2023
Q3 		$867K Buy
+42,020
New +$1.07M 0.01% 1376
2023
Q2 		– Sell
-55,346
Closed -$1.27M – 2543
2023
Q1 		$1.27M Buy
55,346
+5,415
+11% +$149K 0.02% 1044
2022
Q4 		$1.39M Buy
+49,931
New +$1.49M 0.03% 862
2022
Q3 		– Sell
-16,464
Closed -$485K – 2390
2022
Q2 		$485K Buy
+16,464
New +$431K 0.01% 1285
2021
Q2 		– Sell
-39,106
Closed -$2.23M – 1664
2021
Q1 		$2.23M Buy
+39,106
New +$2.62M 0.04% 473
2020
Q3 		– Sell
-37,926
Closed -$917K – 1345
2020
Q2 		$917K Buy
+37,926
New +$892K 0.05% 503

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tudor Investment Corp's DNLI Position: Q2 2026 in Review

Tudor Investment Corp opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 40,965 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #2384 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in DNLI as recently as Q4 2025.

Tudor Investment Corp first reported a position in DNLI in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.23M in Q1 2021. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Tudor Investment Corp held 40,965 shares of Denali Therapeutics worth $1.05M as of Q2 2026.
  • Denali Therapeutics was a new Tudor Investment Corp position in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #2384 holding.
  • Tudor Investment Corp first reported a position in Denali Therapeutics in Q2 2020 and has held it in 13 quarters since.
  • Tudor Investment Corp's Denali Therapeutics position peaked at $2.23M in Q1 2021.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.